Yasuda S, Svergja H, Olsen C, Hoff B
ACS Omega. 2024; 9(12):14142-14152.
PMID: 38559978
PMC: 10976386.
DOI: 10.1021/acsomega.3c09673.
Rana N, Grover P, Singh H
Curr Top Med Chem. 2024; 24(6):541-579.
PMID: 38288806
DOI: 10.2174/0115680266290152240110074034.
Jezuita A, Wieczorkiewicz P, Krygowski T, Szatylowicz H
Molecules. 2023; 28(7).
PMID: 37049758
PMC: 10095612.
DOI: 10.3390/molecules28072993.
Alanazi A, Mirgany T, Alsfouk A, Alsaif N, Alanazi M
Medicina (Kaunas). 2023; 59(3).
PMID: 36984611
PMC: 10051310.
DOI: 10.3390/medicina59030610.
Bertrand J, Dostalova H, Krystof V, Jorda R, Delgado T, Castro-Alvarez A
Pharmaceutics. 2022; 14(6).
PMID: 35745866
PMC: 9228270.
DOI: 10.3390/pharmaceutics14061294.
Synthesis of histidine kinase inhibitors and their biological properties.
Rosales-Hurtado M, Meffre P, Szurmant H, Benfodda Z
Med Res Rev. 2019; 40(4):1440-1495.
PMID: 31802520
PMC: 7272307.
DOI: 10.1002/med.21651.
Azologization of serotonin 5-HT receptor antagonists.
Rustler K, Maleeva G, Bregestovski P, Konig B
Beilstein J Org Chem. 2019; 15:780-788.
PMID: 30992726
PMC: 6444460.
DOI: 10.3762/bjoc.15.74.
Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases.
Goswami M, Wilke K, Carlson E
J Med Chem. 2017; 60(19):8170-8182.
PMID: 28933546
PMC: 5743200.
DOI: 10.1021/acs.jmedchem.7b01066.
Structure-metabolism relationships in AOX: Chemical insights from a large database of aza-aromatic and amide compounds.
Lepri S, Ceccarelli M, Milani N, Tortorella S, Cucco A, Valeri A
Proc Natl Acad Sci U S A. 2017; 114(16):E3178-E3187.
PMID: 28373537
PMC: 5402434.
DOI: 10.1073/pnas.1618881114.
Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.
Swarbrick J, Graeff R, Zhang H, Thomas M, Hao Q, Potter B
J Med Chem. 2014; 57(20):8517-29.
PMID: 25226087
PMC: 4207131.
DOI: 10.1021/jm501037u.
The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents.
Zhang X, Raghavan S, Ihnat M, Thorpe J, Disch B, Bastian A
Bioorg Med Chem. 2014; 22(14):3753-72.
PMID: 24890652
PMC: 4089508.
DOI: 10.1016/j.bmc.2014.04.049.
Three-dimensional mapping of differential amino acids of human, murine, canine and equine TLR4/MD-2 receptor complexes conferring endotoxic activation by lipid A, antagonism by Eritoran and species-dependent activities of Lipid IVA in the mammalian....
Scior T, Lozano-Aponte J, Figueroa-Vazquez V, Yunes-Rojas J, Zahringer U, Alexander C
Comput Struct Biotechnol J. 2014; 7:e201305003.
PMID: 24688739
PMC: 3962092.
DOI: 10.5936/csbj.201305003.
Synthesis and biological activity of 5-chloro-N⁴-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents.
Gangjee A, Zaware N, Raghavan S, Disch B, Thorpe J, Bastian A
Bioorg Med Chem. 2013; 21(7):1857-64.
PMID: 23434139
PMC: 3602277.
DOI: 10.1016/j.bmc.2013.01.040.
Sustainable synthesis and automated deposition: an accessible discovery screening library of fragment-like purines.
Kamper C, Korpis K, Specker E, Anger L, Neuenschwander M, Bednarski P
Mol Divers. 2012; 16(3):541-51.
PMID: 22890959
DOI: 10.1007/s11030-012-9386-x.
N⁴-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation.
Gangjee A, Zaware N, Raghavan S, Yang J, Thorpe J, Ihnat M
Bioorg Med Chem. 2012; 20(7):2444-54.
PMID: 22370340
PMC: 3310894.
DOI: 10.1016/j.bmc.2012.01.029.
3-(2-Fluoro-phen-yl)-6-(phenoxy-meth-yl)-1,2,4-triazolo[3,4-b][1,3,4]thia-diazole.
Holm M, Schollmeyer D, Laufer S
Acta Crystallogr Sect E Struct Rep Online. 2011; 64(Pt 4):o700.
PMID: 21202091
PMC: 2961052.
DOI: 10.1107/S1600536808003917.
Single agents with designed combination chemotherapy potential: synthesis and evaluation of substituted pyrimido[4,5-b]indoles as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.
Gangjee A, Zaware N, Raghavan S, Ihnat M, Shenoy S, Kisliuk R
J Med Chem. 2010; 53(4):1563-78.
PMID: 20092323
PMC: 2825747.
DOI: 10.1021/jm9011142.
Synthesis of chiral 1,4-disubstituted-1,2,3-triazole derivatives from amino acids.
Klein M, Krainz K, Redwan I, Diner P, Grotli M
Molecules. 2009; 14(12):5124-43.
PMID: 20032880
PMC: 6255254.
DOI: 10.3390/molecules14125124.
"Reversine" and its 2-substituted adenine derivatives as potent and selective A3 adenosine receptor antagonists.
Perreira M, Jiang J, Klutz A, Gao Z, Shainberg A, Lu C
J Med Chem. 2005; 48(15):4910-8.
PMID: 16033270
PMC: 3474371.
DOI: 10.1021/jm050221l.